Your browser doesn't support javascript.
loading
Experience with voluntary severe acute respiratory coronavirus virus 2 (SARS-CoV-2) testing of asymptomatic staff at the National Institutes of Health for one year.
Totten, Arthur H; Matlock, Ann Marie; Bailin, Heike; Revoir, Josanne; Siwy, Christopher M; Joyce, Maria; Coffey, Patricia; Henderson, David K; Palmore, Tara N; Frank, Karen M; McKeeby, Jon.
Afiliação
  • Totten AH; Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland.
  • Matlock AM; Nursing Department, Clinical Center, National Institutes of Health, Bethesda, Maryland.
  • Bailin H; Occupational Medical Service, National Institutes of Health, Bethesda, Maryland.
  • Revoir J; Department of Clinical Research Informatics, Clinical Center, National Institutes of Health, Bethesda.
  • Siwy CM; Department of Clinical Research Informatics, Clinical Center, National Institutes of Health, Bethesda.
  • Joyce M; Department of Clinical Research Informatics, Clinical Center, National Institutes of Health, Bethesda.
  • Coffey P; Health Information Management Department, Clinical Center, National Institutes of Health, Bethesda, Maryland.
  • Henderson DK; Hospital Epidemiology Service, Clinical Center, National Institutes of Health, Bethesda, Maryland.
  • Palmore TN; Hospital Epidemiology Service, Clinical Center, National Institutes of Health, Bethesda, Maryland.
  • Frank KM; Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland.
  • McKeeby J; Department of Clinical Research Informatics, Clinical Center, National Institutes of Health, Bethesda.
Infect Control Hosp Epidemiol ; 43(11): 1661-1663, 2022 11.
Article em En | MEDLINE | ID: mdl-34724999
ABSTRACT
Voluntary asymptomatic severe acute respiratory coronavirus virus 2 (SARS-CoV-2) testing was provided by the NIH Clinical Center over 1 year. Among 105,927 tests, 0.2% were positive. Among eligible staff, 79% participated with variable frequency and 61% of positive individuals had symptoms at the time of testing. Saliva specimen collection was chosen as an option less frequently than midturbinate collection.
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Diagnostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Diagnostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article